The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
- PMID: 36163009
- PMCID: PMC9511724
- DOI: 10.1186/s12885-022-10069-6
The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
Abstract
Background: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by chance. This study aimed to examine the association between BC and TC in the Netherlands.
Methods: This is a retrospective cohort study during the period of 1989-2020 retrieved from the Netherlands Cancer Registry (NCR). Patients diagnosed with BC-TC and BC alone as control group and TC-BC and TC alone as control group were included. The primary outcome was the standardized incidence ratio (SIR) of BC-TC and TC-BC. Secondary outcomes included data on the demographics, type of malignancy, treatment and overall survival (OS).
Results: The incidence of TC among 318.002 women with BC (BC-TC) was 0.1% (423 patients) (SIR = 1.86 (95% CI: 1.40-2.32)) and the incidence of BC among 12,370 patients with TC (TC-BC) was 2.9% (355 patients) (SIR = 1.46 (95% CI: 1.09-1.83)). BC-TC patients were younger compared to the BC alone group at BC diagnosis (55 vs 60 years, p < 0.001). The age-adjusted odds ratio to develop TC was not significantly increased for patients who received chemotherapy and radiotherapy. Most TC cases were synchronous tumors after BC diagnosis (19%) with a TNM stage 1. Only 6% of the BC tumors after TC occurred synchronous with a TNM stage 1 in most cases. The OS of all groups was the most favorable in patients with both BC and TC compared to BC- and TC alone.
Conclusion and relevance: The SIR of TC after BC diagnosis and BC after TC diagnosis was higher than predicted based on the rates of the general population. TC and BC as second primary tumors were diagnosed in an early stage and did not affect overall survival. Therefore, Dutch women who have been treated for BC or TC require no special surveillance for their thyroid- and breast gland.
Keywords: Association; Incidence; Reast cancer; Survival; Thyroid cancer.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer.Cancer Med. 2018 Dec;7(12):6393-6400. doi: 10.1002/cam4.1856. Epub 2018 Nov 27. Cancer Med. 2018. PMID: 30480382 Free PMC article.
-
A Possible Association Between Thyroid Cancer and Breast Cancer.Thyroid. 2015 Dec;25(12):1330-8. doi: 10.1089/thy.2014.0561. Epub 2015 Oct 27. Thyroid. 2015. PMID: 26442580
-
Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.Oncotarget. 2016 Aug 9;7(32):52450-52459. doi: 10.18632/oncotarget.9547. Oncotarget. 2016. PMID: 27223440 Free PMC article.
-
[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].Cancer Radiother. 1997;1(4):300-6. doi: 10.1016/s1278-3218(97)81497-7. Cancer Radiother. 1997. PMID: 9435820 Review. French.
-
[Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].Zentralbl Chir. 2012 Dec;137(6):565-74. doi: 10.1055/s-0031-1283939. Epub 2012 Mar 16. Zentralbl Chir. 2012. PMID: 22426967 Review. German.
Cited by
-
Breast cancer and neoplasms of the thyroid gland: a bidirectional two-sample Mendelian randomization study.Front Oncol. 2024 Oct 14;14:1422009. doi: 10.3389/fonc.2024.1422009. eCollection 2024. Front Oncol. 2024. PMID: 39469634 Free PMC article.
-
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer.Breast Cancer Res Treat. 2024 Aug;206(3):585-594. doi: 10.1007/s10549-024-07331-9. Epub 2024 Jun 12. Breast Cancer Res Treat. 2024. PMID: 38864980 Free PMC article.
-
Breast cancer as the first primary malignancy: clinical pathological characteristics of common cancer combinations.Discov Oncol. 2025 Aug 23;16(1):1599. doi: 10.1007/s12672-025-03427-w. Discov Oncol. 2025. PMID: 40848178 Free PMC article. Review.
-
Risk of second primary thyroid cancer in cancer survivors.Sci Rep. 2024 May 30;14(1):12478. doi: 10.1038/s41598-024-63155-z. Sci Rep. 2024. PMID: 38816510 Free PMC article.
-
Ectopic thyroid tissue in the breast: A case report.Open Life Sci. 2023 Jun 14;18(1):20220628. doi: 10.1515/biol-2022-0628. eCollection 2023. Open Life Sci. 2023. PMID: 37333484 Free PMC article.
References
-
- Morrow M, Burstein HJ, Harris JR. Malignant tumors of the breast. 2015.
-
- Howlader, N., Noone, A.M., Krapcho, M., et al. (2019) SEER Explorer. Breast Cancer-Stage Distribution of SEER Incidence Cases, 2007–2016 by Sex. National Cancer Institute, Bethesda.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical